Skip to Main Content

Federal prosecutors indicted Teva Pharmaceuticals (TEVA) of conspiring with other manufacturers of fixing prices for generic drugs, the seventh drug maker to be accused as part of a long-running government probe.

The Department of Justice alleged the company, which is one of the world’s largest purveyors of copycat medicines, participated in three conspiracies from at least as early as May 2013 until at least in or around Dec. 2015. The drug maker allegedly coordinated with several other companies to set prices for medicines to treat high cholesterol, arthritis, seizures, pain, skin conditions, blood clots. brain cancer, cystic fibrosis, arthritis, and hypertension.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!